| HCVCX | OICAX | HCVCX / OICAX | |
| Total Expense Ratio | 1.80 | 0.93 | 194% |
| Annual Report Gross Expense Ratio | 1.80 | 0.93 | 194% |
| Fund Existence | 22 years | 29 years | - |
| Gain YTD | 0.927 | 0.978 | 95% |
| Front Load | N/A | 5% | - |
| Min. Initial Investment | 2000 | 500 | 400% |
| Min. Initial Investment IRA | 2000 | N/A | - |
| Net Assets | 143M | 4.43B | 3% |
| Annual Yield % from dividends | 2.39 | 3.21 | 74% |
| Returns for 1 year | 9.74 | 8.66 | 112% |
| Returns for 3 years | 24.36 | 21.17 | 115% |
| Returns for 5 years | 11.32 | 10.60 | 107% |
| Returns for 10 years | 52.97 | 40.71 | 130% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| AIORX | 12.51 | 0.18 | +1.46% |
| American Century International Opps R | |||
| FVALX | 6.16 | 0.06 | +0.98% |
| Forester Value N | |||
| GIDUX | 9.01 | 0.01 | +0.11% |
| Goldman Sachs Intl Eq Div & Prem R6 | |||
| GIEZX | 16.49 | N/A | N/A |
| GuideStone Funds International Eq Inv | |||
| JAGLX | 81.26 | -0.51 | -0.62% |
| Janus Henderson Global Life Sciences T | |||